Health Services Research & Development

Go to the ORD website
Go to the QUERI website

ESP Report: Management of Antiplatelet Therapy Among Patients on Antiplatelet Therapy for Cerebrovascular or Peripheral Vascular Diseases Undergoing Elective Non-cardiac Surgery

Click for list of published reports
Click for topic nomination form
Click for list of reports in progress

Subscribe to the
ESP Report RSS feed RSS feed icon
ESP Report: Management of Antiplatelet Therapy Among Patients on Antiplatelet Therapy for Cerebrovascular or Peripheral Vascular Diseases Undergoing Elective Non-cardiac Surgery

Principal Investigator: Paul Shekelle, MD PhD
Co-Investigators: Melinda Maggard-Gibbons, MD, MSHS; Isomi M. Miake-Lye, PhD; Christopher P. Childers, MD; Sean M. O'Neill, MD, PhD Contributing Investigators: Selene Mak, PhDc; Roberta Shanman, MLS; Jessica M. Beroes, BS



Evidence-based Synthesis Program (ESP) Center, West Los Angeles VA Medical Center, DLos Angeles, CA; Washington (DC): Department of Veterans Affairs; October 2017.

Download PDF: Complete Report, Abstract, Report, Appendices



Introduction

The perioperative management of antiplatelet therapy (APT) for patients with cerebrovascular or peripheral vascular diseases remains unclear.

This review was requested to assess the evidence for the following Key Questions:

1. Among patients on APT for cerebrovascular disease or peripheral vascular disease undergoing elective non-cardiac surgical procedures, including intraocular procedures, what are the benefits and harms of holding APT prior to surgery?

2. How does benefit/risk vary by the timing of discontinuation?

3. How does benefit/risk vary by type of surgical procedure, including intraocular procedures?

4. How does benefit/risk vary by type of APT?

5. How does benefit/risk vary by the timing of resuming APT?

See also

Systematic Review: Management of Antiplatelet Therapy among Patients Undergoing Elective Non-Cardiac Surgery (Management eBrief)